Firms/companies
Tata Motors' Tigor EVs based on Tiago platform
07 Dec 2017
Nestle to buy Canadian vitamin maker Atrium for $2.3 bn
07 Dec 2017
Swiss food and drink giant Nestle SA yesterday struck a deal to buy Canadian privately-held vitamin maker Atrium Innovations for $2.3 billion in order to expand its consumer healthcare portfolio
Nestle to buy Canadian vitamin maker Atrium for $2.3 bn
07 Dec 2017
Swiss food and drink giant Nestle SA yesterday struck a deal to buy Canadian privately-held vitamin maker Atrium Innovations for $2.3 billion in order to expand its consumer healthcare portfolio
Nestle to buy Canadian vitamin maker Atrium for $2.3 bn
07 Dec 2017
Swiss food and drink giant Nestle SA yesterday struck a deal to buy Canadian privately-held vitamin maker Atrium Innovations for $2.3 billion in order to expand its consumer healthcare portfolio
Tata Motors rolls out first batch of Tigor EVs from Sanand plant
06 Dec 2017
Tata Motors said the electric drive systems for the Tigor EVs have been developed and supplied by Electra EV, a company that develops and supplies electric drive systems for the automotive sector
RBI keeps repo rate unchanged at 6%; projects a spike in inflation
06 Dec 2017
With crude prices on the boil and vegetable prices rising steadily, RBI has raised the inflation forecast for the next two quarters from 4.2-4.6 per cent to 4.3- 4.7 per cent
Apple to start paying Ireland €13 billion in unpaid taxes
05 Dec 2017
Apple today reached an agreement with the European Union to pay €13 billion to Ireland in unpaid taxes, following the landmark decision by the European regulator to crack down on companies parking their profits in low-tax havens in Europe
WHO to review Sanofi’s dengue vaccine Dengvaxia over safety concerns
05 Dec 2017
The review comes after the French pharma giant’s own admission that its dengue vaccine could have unintended consequences in patients who had never been infected with the mosquito-borne virus and the Philippines halted its use
WHO to review Sanofi’s dengue vaccine Dengvaxia over safety concerns
05 Dec 2017
The review comes after the French pharma giant’s own admission that its dengue vaccine could have unintended consequences in patients who had never been infected with the mosquito-borne virus and the Philippines halted its use